ArticleFrontiers in physiology2025
Development and validation of a machine learning model based on multiple kernel for predicting the recurrence risk of Budd-Chiari syndrome.
Article in Frontiers in physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association Between Systemic Inflammation Indices and Recurrence Risk in Primary Budd-Chiari Syndrome.Journal of inflammation research · 2026Article
- Budd-Chiari syndrome: Prognostic scores, special populations, and management challenges.World journal of gastroenterology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Budd-Chiari syndrome (BCS) is a rare global condition with high recurrence rates. Existing prognostic scoring models demonstrate limited predictive efficacy for BCS recurrence. This study aims to develop a novel machine learning model based on multiple kernel learning to improve the prediction of 3-year recurrence in BCS patients. Methods: Data were collected from BCS patients admitted to the Affiliated Hospital of Xuzhou Medical University between January 2015 and July 2022. The dataset was divided into training, validation, and test sets in a 6:2:2 ratio. Models were constructed by evaluating all combinations of four kernel functions in the training set. Hyperparameters for each model were optimized using the particle swarm optimization (PSO) algorithm on the validation set. The test set was used to compare kernel function combinations, with the area under the curve (AUC), sensitivity, specificity, and accuracy as evaluation metrics. The optimal model, identified through the best-performing kernel combination, was further compared with three classical machine learning models. Result: A kernel combination integrating all four basic kernels achieved the highest average AUC (0.831), specificity (0.772), and accuracy (0.780), along with marginally lower but more stable sensitivity (0.795) compared to other combinations. When benchmarked against classical machine learning models, our proposed MKSVRB (Multi-Kernel Support Vector Machine Model for Three-Year Recurrence Prediction of Budd-Chiari Syndrome) demonstrated superior performance. Additionally, it outperformed prior studies addressing similar objectives. Conclusion: This study identifies risk factors influencing BCS recurrence and validates the MKSVRB model as a significant advancement over existing prediction methods. The model exhibits strong potential for early detection, risk stratification, and recurrence prevention in BCS patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.